What is this study trying to find out about acute respiratory infections?

This study aims to understand how acute respiratory infections are diagnosed and treated in adults in hospital settings across Europe. Researchers want to see what tests and treatments are used and how patients recover. This information can help improve care and guide future treatment strategies.

Who may be eligible for this acute respiratory infection clinical trial?

Adults aged 18 years or older with a new suspected acute respiratory tract infection starting within the last 10 days and presenting to an emergency room or hospital setting may be eligible. Participants must provide informed consent and not be transferred from another hospital or already enrolled. Please review eligibility criteria for more details.

Is there any cost to participate in this acute respiratory infection clinical trial?

Study-related care, including data collection and all trial visits, is provided at no cost. Personal travel expenses may vary and are not guaranteed to be covered. Participants can expect no charges related to the study procedures.

Actively Recruiting

Age: 18Years +

All Genders

ID05814237

Perpetual Observational Study of Acute Respiratory Infections Presenting Via Emergency Rooms and Other Acute Hospital Care Settings

Led by European Clinical Research Alliance for Infectious Diseases (ECRAID) · Updated on 2024-09-19

11750

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Acute respiratory infections ARI are a common cause of hospital admissions and antibiotic use, caused by various pathogens including viruses like influenza and coronaviruses. This observational study aims to describe routine diagnostic and treatment practices for ARI and to characterize the adult patient population presenting with ARI in acute hospital settings across Europe. The study also seeks to understand the causes of ARI in these patients and variations in clinical outcomes. The study collects data from adults with ARI who visit emergency rooms or acute medical assessment units, including those admitted to hospital and those discharged the same day. Diagnostic methods such as laboratory and point of care tests, as well as pharmacological treatments like antibiotics and antivirals, are recorded. A subset of participants will have a respiratory sample taken within 24 hours to identify pathogens using molecular methods. Participants will undergo data collection about their clinical condition, laboratory tests, and treatments received. Researchers will track the use of microbiology and virology tests, antibiotic and antiviral treatments, clinical outcomes, hospital and ICU stays, and mortality up to 28 days after admission or discharge. Patient demographics, symptoms, comorbidities, physiological measurements, and ARI causes will also be studied. The study is ongoing and observational, with no direct interventions beyond data collection.

CONDITIONS

Brief Title

POS-ARI-ER Observational Study of Acute Respiratory Infections

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

Age 18 years or older
Clinical suspicion of a new episode of acute respiratory tract infection with onset in the last 10 days
Patient presents to an emergency room or secondary care setting
Informed consent provided by patient or legal representative

You will not qualify if you...

Patient transferred from another hospital
Patient admitted to hospital for more than 2 days at time of enrolment
Patient previously enrolled in the POS-ARI-ER study

Research Team

Yrene Themistocleous

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here